Your browser doesn't support javascript.
Achems clinical symposium: The cure for olfactory loss
Chemical Senses ; 46, 2021.
Article in English | EMBASE | ID: covidwho-1664103
ABSTRACT
The corona pandemic made it painfully clear to a broader public that there are limited options for the treatment of olfactory loss. Hence, the title of the symposium is provocative. Having said this, major advances in the understanding of olfactory loss have been made during the alst 20 years. Several options for treatment have been investigated, so that their possibilities and limitations are now clearer. The symposium will almost exclusively include presentations from medical doctors who see patients with olfactory loss on a daily basis. Speakers come from the USA, the UK and France, and all of them are widely recognized researchers. First, Katie Whitcroft form London will talk about corticosteroids which are the most frequently used drugs in the treatment of olfactory loss. Vijay Ramakrishnan from Aurora will deal with the nasal microbiome which may play a major role in olfactory loss. Andrew Lane from Baltimore will then talk about most recent advances in the understanding of the mechanisms of olfactory loss associated with inflammatory conditions - which are the cause of approximately 2/3 of all olfactory disorders, apart from aging. Finally, Moustafa Bensafi from Lyon will shed light on current developments in new therapeutic options including olfactory implants.
Keywords

Full text: Available Collection: Databases of international organizations Database: EMBASE Type of study: Prognostic study Language: English Journal: Chemical Senses Year: 2021 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: Databases of international organizations Database: EMBASE Type of study: Prognostic study Language: English Journal: Chemical Senses Year: 2021 Document Type: Article